Drug And Alcohol Screening Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Sample Type, (Urine, Breath, Oral Fluid, Blood, Others), By End-User (Hospitals And Treatment Facilities, Law And Enforcement, Sporting Events, Others), And By Geography - Forecasts From 2019 To 2024

Published:  May 2021 Report Code: KSI061612394 Pages: 121

Drug and alcohol screening test mainly analyze biological samples such as urine, blood, and hair to diagnose the presence of the drug. The rise in alcohol consumption, overuse of prescribed drugs, the rise in usage of narcotics and illicit drugs are driving the global drug and alcohol screening market. The drug and alcohol screening market are projected to grow at a CAGR of 11.75% by the year 2024. The enforcement of strict laws and regulation in various countries and financial support from the government are the key growth factors of drug and alcohol screening market.

Rise in alcohol and drug abuse, growing knowledge, and awareness among developing countries, growing aging population and competition among leading manufacturers in drug and alcohol screening market for innovative products are the reason for the increasing demand for drug and alcohol screening. Technological advancement is expected to boost the market over the world for the forecast period. The ban on alcohol and drug consumption in some countries and accuracy issues in testing instruments are hindering the growth of the market in the coming years.

In terms of geography, the global drug and alcohol screening market has been classified into North America, South America, Middle East, and Africa, Europe, and Asia-Pacific. Government policies towards drug usage are helping to grow more in North America. Asia-Pacific region is going to be a new hub for exporting dug screening instruments. Companies like, Alere Inc. has started its operation in India in 2016.

Key players operating in the global drug and alcohol screening market are Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd and OraSure Technologies, among others. 

Drug And Alcohol Screening Market Scope:

Report Metric Details
 Growth Rate  CAGR of 11.75% during the forecast period
 Base year  2019
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Sample Type, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered Abbott, Premier Biotech, Inc., Drägerwerk AG & Co., OraSure Technologies Inc., Alfa Scientific Designs, Inc., Lifeloc Technologies Inc., Express Diagnostics Int’l, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Siemens Healthineers
 Customization scope  Free report customization with purchase

 

Segmentation

The drug and alcohol screening market has been analyzed through the following segments:

  • By Sample Type
    • Urine
    • Breath
    • Oral Fluid
    • Blood
    • Others
  • By End-User
    • Hospitals and Treatment Facilities
    • Law and Enforcement
    • Sporting Events
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Others
    • Middle East and Africa
      • Israel
      • South Africa
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Others

Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for drug and alcohol screening market?
A1. The drug and alcohol screening market is projected to grow at a CAGR of 11.75% during the forecast period.

Q2. Who are the major players in the drug and alcohol screening market?
A2. Key players operating in the global drug and alcohol screening market are Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and OraSure Technologies, among others. 

Q3. How is the global drug and alcohol screening market segmented?
A3. The global drug and alcohol screening market has been segmented by sample type, end-user, and geography.

Q4. What factors are anticipated to drive the drug and alcohol screening market growth?
A4. The enforcement of strict laws and regulations in various countries and financial support from the government are the key growth factors of the drug and alcohol screening market.

Q5. Which region holds the largest market share in the drug and alcohol screening market?
A5. North America holds a noteworthy share in the drug and alcohol screening market.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
 
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
 
3. EXECUTIVE SUMMARY
 
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
 
5. DRUG AND ALCOHOL SCREENING MARKET BY SAMPLE TYPE
5.1. Urine
5.2. Breath
5.3. Oral Fluid
5.4. Blood
5.5. Others
 
6. DRUG AND ALCOHOL SCREENING MARKET BY END-USER
6.1. Hospitals and Treatment Facilities
6.2. Law and Enforcement
6.3. Sporting Events
6.4. Others
 
7. DRUG AND ALCOHOL SCREENING MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. UAE
7.4.2. Israel
7.4.3. Saudi Arabia
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan 
7.5.3. India
7.5.4. South Korea
7.5.5. Others
 
8. COMPETITIVE INTELLIGENCE
8.1. Market Positioning Matrix and Ranking
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
 
9. COMPANY PROFILES
9.1. Abbott 
9.2. Premier Biotech, Inc.
9.3. Drägerwerk AG & Co. 
9.4. OraSure Technologies Inc.
9.5. Alfa Scientific Designs, Inc.
9.6. Lifeloc Technologies Inc.
9.7. Express Diagnostics Int’l
9.8. F. Hoffmann-La Roche Ltd 
9.9. Shimadzu Corporation
9.10. Siemens Healthineers
 

Abbott

Premier Biotech, Inc.

Drägerwerk AG & Co.

OraSure Technologies Inc.

Alfa Scientific Designs, Inc.

Lifeloc Technologies Inc.

Express Diagnostics Int’l

F. Hoffmann-La Roche Ltd

Shimadzu Corporation

Siemens Healthineers

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us